304p * assessment of bisphosphonates use as adjuvant therapy in breast cancer

Conclusions: Adding zoledronic acid to adjuvant letrozole in postmeopausal breast cancer patients improves bone health as shown by BMD and Ntx.Disclosure: All authors have declared no conflicts of interest.

Source: Annals of Oncology - September 24, 2014 Category: Cancer & Oncology Authors: Abu-Taleb, F. M., El-Zawahry, H. M., Zekri, Z. K., Gaafar, R. M. M., Al Lahloubi, N. M. A., Zakhari, N., Elfarargy, O., Alnagar, A. A. R. Tags: breast cancer, early stage Source Type: research